BNIP3 upregulation characterizes cancer cell subpopulation with increased fitness and proliferation
Preprint
Abstract
BNIP3 is a BH3 only protein with both pro-apoptotic and pro-survival roles depending on the cellular context. It remains unclear how BNIP3 RNA level dictates cell fate decisions of cancer cells. Here we undertook a quantitative analysis of BNIP3 expression and functions in single cell datasets of various epithelial malignancies. Our results demonstrated that BNIP3 upregulation characterizes cancer cell subpopulations with increased fitness and proliferation. We further validated the upregulation of BNIP3 in liver cancer organoids compared with 2D culture. Taken together, the combination of in silico perturbations using public single cell datasets and experimental cancer modeling using organoids ushered in a new approach to address cancer heterogeneity.Keywords
All Related Versions
- Published version: Frontiers in Oncology, 12, 923890.
This publication has 30 references indexed in Scilit:
- Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seqScience, 2016
- PD‐L1 expression is regulated by hypoxia inducible factor in clear cell renal cell carcinomaInternational Journal of Cancer, 2016
- StringTie enables improved reconstruction of a transcriptome from RNA-seq readsNature Biotechnology, 2015
- GSVA: gene set variation analysis for microarray and RNA-Seq dataBMC Bioinformatics, 2013
- Modulation of Serines 17 and 24 in the LC3-interacting Region of Bnip3 Determines Pro-survival Mitophagy versus ApoptosisJournal of Biological Chemistry, 2013
- BNIP3 protects HepG2 cells against etoposide-induced cell death under hypoxia by an autophagy-independent pathwayBiochemical Pharmacology, 2010
- Overexpression of BH3-Only Protein BNIP3 Leads to Enhanced Tumor GrowthGenes & Cancer, 2010
- Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosisNature, 2009
- BNIP3 subfamily BH3-only proteins: mitochondrial stress sensors in normal and pathological functionsOncogene, 2008
- The Von Hippel-Lindau Tumor Suppressor Gene and Kidney CancerClinical Cancer Research, 2004